Lawmakers, Experts on PBMs: ‘Gangsters’ or Scapegoats in the Drug Price Wars?
Expert witnesses and lawmakers tussled over who is really to blame for high drug costs during a hearing focused on pharmacy benefit managers (PBMs) held by the House Committee on Oversight and Accountability on Tuesday. While PBMs are meant to lower costs by negotiating rebates on a drug’s list price, multiple experts have noted that […]